Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 26,936 $ 24,983
Marketable securities, current 77,489 118,061
Prepaid expenses 2,395 3,917
Other current assets 4,358 1,254
Total current assets 111,178 148,215
Marketable securities, non-current 0 8,986
Operating lease right-of-use assets 7,794 8,608
Property and equipment, net 17,913 19,309
Other assets 4,006 7,244
Total assets 140,891 192,362
Current liabilities:    
Accounts payable 1,641 1,612
Accrued liabilities 9,291 9,515
Deferred revenue, current 32,984 32,937
Other current liabilities 2,459 2,606
Total current liabilities 46,375 46,670
Deferred revenue, long-term 22,662 33,350
Long-term debt, net of current portion 35,675 35,491
Operating lease liabilities 8,444 9,564
Other liabilities 1,698 1,625
Total liabilities 114,854 126,700
Commitments and contingencies (Note 10) 0 0
Stockholders’ equity    
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares at June 30, 2022 and December 31, 2021; issued and outstanding: 250 shares at June 30, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value: Authorized: 150,000,000 shares at June 30, 2022 and December 31, 2021; issued and outstanding: 56,339,558 shares at June 30, 2022 and 56,305,049 shares at December 31, 2021 56 56
Additional paid-in capital 424,392 417,704
Accumulated other comprehensive loss (330) (48)
Accumulated deficit (398,081) (352,050)
Total stockholders’ equity 26,037 65,662
Total liabilities and stockholders’ equity $ 140,891 $ 192,362